🕵️ LENZ Therapeutics, Inc. ($LENZ)
SEC insider & ownership activity, last 12 months · CIK 1815776 · every row links its SEC filing
Insider buy and sell values were withheld pending verification over the last 12 months. RA Capital Management, L.P. trimmed 15.1% → 13.6%; Peter Kolchinsky trimmed 15.1% → 13.6%. No red-flag 8-Ks in the window.
Insider flow
4 buyers, value withheld pending verification (6 lots) · 2 sellers, value withheld pending verification (14 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Evert B. Schimmelpennink | 1 | $251K | 0 | – | Mar 27, 2026 |
| Daniel R. Chevallard | 3 | value withheld pending verification | 0 | – | Mar 27, 2026 |
| Jeffrey P. George | 1 | $50K | 0 | – | Mar 27, 2026 |
| James W. McCollum | 1 | value withheld pending verification | 0 | – | Nov 7, 2025 |
| Shawn Olsson | 0 | – | 2 | value withheld pending verification | Nov 17, 2025 |
| Versant Venture Capital VI, L.P. | 0 | – | 12 | value withheld pending verification | Sep 30, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | 13.6% | 13D | Nov 5, 2025 | filing ↗ | |
| Peter Kolchinsky | 13.6% | 13D | Nov 5, 2025 | filing ↗ | |
| Rajeev Shah | 13.6% | 13D | Nov 5, 2025 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 10.8% | 13D | Nov 5, 2025 | filing ↗ | |
| BlackRock, Inc. | 5.8% | 13G | Apr 27, 2026 | filing ↗ | |
| FMR LLC | 5.7% | 13G | Sep 8, 2026 | filing ↗ | |
| Abigail P. Johnson | 5.7% | 13G | Sep 8, 2026 | filing ↗ | |
| Squarepoint OPS LLC | 5.1% | 13G | Apr 8, 2026 | filing ↗ | |
| Squarepoint Capital LLP | 5.1% | 13G | Apr 8, 2026 | filing ↗ | |
| Squarepoint Operations Private Limited | 5.1% | 13G | Apr 8, 2026 | filing ↗ | |
| Squarepoint (DIFC) Ltd | 5.1% | 13G | Apr 8, 2026 | filing ↗ | |
| Squarepoint Master Fund Limited | 5.1% | 13G | Apr 8, 2026 | filing ↗ | |
| Millennium Management LLC | 5.1% | 13G | Jun 26, 2026 | filing ↗ | |
| Millennium Group Management LLC | 5.1% | 13G | Jun 26, 2026 | filing ↗ | |
| Israel A. Englander | 5.1% | 13G | Jun 26, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Shawn Olsson | $1.0M | Nov 17, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 12, 2026 | filing ↗ |
| Earnings (2.02) | May 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 11, 2026 | filing ↗ |
| Earnings (2.02) | Mar 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 24, 2026 | filing ↗ |
| Earnings (2.02) | Jan 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 7, 2026 | filing ↗ |
| Other events (8.01) | Dec 12, 2025 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Other events (8.01) | Oct 8, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 30, 2025 | filing ↗ |
| Other events (8.01) | Sep 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 30, 2025 | filing ↗ |